Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/15/2009US20090258899 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
10/15/2009US20090258898 Amides of acetic and propionic acids
10/15/2009US20090258897 Substituted benzimidazoles
10/15/2009US20090258896 Composition comprising at least one higher aliphatic alcohol and an extract of griffonia simplicifolia
10/15/2009US20090258895 Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus)
10/15/2009US20090258894 Fused Aminopiperidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
10/15/2009US20090258893 Fused quinoline derivative and use thereof
10/15/2009US20090258892 Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
10/15/2009US20090258891 Macrocyclic Compounds As Antiviral Agents
10/15/2009US20090258890 Topoisomerase-targeting agents
10/15/2009US20090258888 Pyrimidine Derivatives
10/15/2009US20090258887 Novel Carboxylic Acid Derivatives
10/15/2009US20090258886 Heteroalkyl linked pyrimidine derivatives
10/15/2009US20090258885 Diphenylmethane Derivatives as Inhibitors of Leukotriene Biosynthesis
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258883 1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds
10/15/2009US20090258882 2,4-Substituted Quinazolines as Lipid Kinase Inhibitors
10/15/2009US20090258881 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
10/15/2009US20090258880 Substituted Tetrahydropyrrolopyrazine Compounds and the Use Thereof in Pharmaceutical Compositions
10/15/2009US20090258879 Method for treating cancer, rheumatoid arthritis and other medical diseases by utilizing modified virus virions to insert medications into targeted cells
10/15/2009US20090258878 Triazine derivative compound and composition for treating cancer containing them
10/15/2009US20090258877 Triazolotriazines and triazolopyrazines and their use
10/15/2009US20090258876 Novel indol carboxylic acid bispyridyl carboxamide derivatives, pharmaceutically acceptable salt thereof, preparation method and composition containing the same as an active ingredient
10/15/2009US20090258874 Pyrazolo-heteroaryl compounds
10/15/2009US20090258873 Novel tetrahydropyridothiophenes
10/15/2009US20090258872 Use of aryl-substituted polycyclic amines as medicaments
10/15/2009US20090258871 Aza-Substituted Spiro Derivatives
10/15/2009US20090258870 Novel ansamitocin derivatives
10/15/2009US20090258869 Methods and compounds for treatment or prevention of substance-related disorders
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009US20090258867 Pyrazolo[1,5-a] pyrimidine compounds as cb1 receptor antagonist
10/15/2009US20090258866 CGRP Receptor Antagonists
10/15/2009US20090258865 Administration of benzodiazepine compositions
10/15/2009US20090258864 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
10/15/2009US20090258863 Method for treatment of amyotrophic lateral sclerosis using talampanel
10/15/2009US20090258862 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/15/2009US20090258861 Tetrahydronaphthyridine Derivatives
10/15/2009US20090258860 Xanthine derivatives for the treatment of vascular depression
10/15/2009US20090258859 Metronidazole cocrystals and imipramine cocrystals
10/15/2009US20090258858 Muscarinic acetylcholine receptor antagonists
10/15/2009US20090258857 Chemical compounds
10/15/2009US20090258856 Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
10/15/2009US20090258855 Bicyclic triazoles as protein kinase modulators
10/15/2009US20090258854 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase
10/15/2009US20090258853 Somatostatin Agonists
10/15/2009US20090258852 Inhibitors of Checkpoint Kinases
10/15/2009US20090258851 Diaryl substituted alkanes
10/15/2009US20090258850 Stabilized therapeutic compositions and formulations
10/15/2009US20090258849 Nitrooxy derivatives of glucocorticoids
10/15/2009US20090258848 Biomarkers for inflammatory bowel disease
10/15/2009US20090258847 Cholanic Acid Amides
10/15/2009US20090258846 Eyebrow re-growth stimulator for re-growth of lost eyebrows
10/15/2009US20090258845 Combination Dosage Forms and Therapies for Supporting Bone Health
10/15/2009US20090258844 Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
10/15/2009US20090258843 Compositions Containing Antiviral Compounds and Methods of Using the Same
10/15/2009US20090258842 such as 7-(2,4-difluorophenyl)sancycline, used for the treatment of bacterial infections in mammals
10/15/2009US20090258841 Compositions and methods for skin care
10/15/2009US20090258840 Method and compositions for treating hematological malignancies
10/15/2009US20090258839 Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome
10/15/2009US20090258838 Gel formulation
10/15/2009US20090258837 Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation
10/15/2009US20090258836 Effective delivery of cross-species a3 adenosine-receptor antagonists to reduce intraocular pressure
10/15/2009US20090258835 Compounds that stimulate glucose utilization and methods of use
10/15/2009US20090258832 Cytokines and Cytokine Receptors With Reduced Immunocencity
10/15/2009US20090258826 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
10/15/2009US20090258817 Arylsulfanyl compounds and compositions for delivering active agents
10/15/2009US20090258426 Preferred segments of neural thread protein and method of using the same
10/15/2009US20090258363 Targeted integration and expression of exogenous nucleic acid sequences
10/15/2009US20090258098 Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
10/15/2009US20090258094 Xanthohumol-enriched hop extract
10/15/2009US20090258090 Colon cleansing solution
10/15/2009US20090258089 Chemo- and Radiation-sensitization of Cancer by Antisense TRPM-2 Oligodeoxynucleotides
10/15/2009US20090258086 Biofilm extracellular polysaccharide solvating system
10/15/2009US20090258084 Mono and Combination Therapy with a M1/M4 Muscarinic Agonist (Sabcomeline) for Treatment of Cognitive Disorders in Schizophrenia
10/15/2009US20090258081 New plant derived seed extract rich in essentially fatty acids derived from salvia hispanica l. seed: composition of matter, manufacturing process and use
10/15/2009US20090258075 Respiratory Drug Condensation Aerosols and Methods of Making and Using Them
10/15/2009US20090258071 Compositions and methods for ph targeted drug delivery
10/15/2009US20090258070 Topical LFA-1 antagonists for use in localized treatment of immune related disorders
10/15/2009US20090258069 Delivery of LFA-1 antagonists to the gastrointestinal system
10/15/2009US20090258067 Modified release composition of at least one form of venlafaxine
10/15/2009US20090258065 Dermatological compositions comprising avermectin nanocapsules
10/15/2009US20090258064 Compositions of ucp inhibitors, fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
10/15/2009US20090258062 Transdermal Therapeutic System Comprising Active Ingredient Particles and Having Increased Active Ingredient Flux
10/15/2009US20090258061 Once-a-day replacement transdermal administration of fentanyl
10/15/2009US20090258058 Novel silicone film former for delivery of actives
10/15/2009US20090258055 Heparin Prodrugs and Drug Delivery Stents Formed Therefrom
10/15/2009US20090258054 Heparin Prodrugs and Drug Delivery Stents Formed Therefrom
10/15/2009US20090258053 Medical stent provided with a combination of melatonin and paclitaxel
10/15/2009US20090258052 Compounds and methods for altering bone growth
10/15/2009US20090258050 Controlled Drug Delivery Using a Zein Layer Modified with Levulinic Acid
10/15/2009US20090258049 Drug eluting expandable devices
10/15/2009US20090258046 Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
10/15/2009US20090258040 Steroid treatment for hot flashes
10/15/2009US20090258039 Method of administering a pharmaceutical active ingredient
10/15/2009US20090258038 Water-soluble compositions of bioactive lipophilic compounds
10/15/2009US20090258036 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3' -utr of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
10/15/2009US20090258033 HCV E1E2 vaccine compositions
10/15/2009US20090258030 Materials and Methods for Improving Livestock Productivity
10/15/2009US20090258027 Methods of modulating immune function
10/15/2009US20090258023 Tgf-beta superfamily binding proteins and modulation of bone formation and loss
1 ... 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 ... 7860